Literature DB >> 17613937

Neuropeptide S: a novel modulator of stress and arousal.

Naoe Okamura1, Rainer K Reinscheid.   

Abstract

Neuropeptide S (NPS) is a recently identified bioactive peptide that modulates stress and arousal. NPS is expressed in a few discrete nuclei in the brainstem, such as the pericoerulear (locus coeruleus (LC)) area and the parabrachial nucleus. NPS activates its cognate G protein-coupled receptor at low nanomolar agonist concentrations and induces elevation of intracellular Ca2+ and cAMP, therefore acting as an excitatory transmitter. The NPS receptor is widely expressed in the brain, including regions known to regulate stress responses such as hypothalamus, thalamus, amygdala and limbic cortex. We have recently reported that the NPS system can modulate stress responses and induce wakefulness based on a battery of behavioral tests. Activation of NPS receptors induces arousal and reduces all sleep stages. At the same time, NPS produces anxiolytic-like effects in rodents. These studies indicate that the NPS system has a unique pharmacological profile to promote both anxiolytic and arousal effects. NPS might interact with other hypothalamic neuropeptide systems that are known to be involved in stress and appetite control and thus might be a valuable target for development of a new class of drugs to treat anxiety disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613937     DOI: 10.1080/10253890701248673

Source DB:  PubMed          Journal:  Stress        ISSN: 1025-3890            Impact factor:   3.493


  26 in total

1.  Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex.

Authors:  Wei Si; Leah Aluisio; Naoe Okamura; Stewart D Clark; Ian Fraser; Steven W Sutton; Pascal Bonaventure; Rainer K Reinscheid
Journal:  J Neurochem       Date:  2010-08-30       Impact factor: 5.372

2.  Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor.

Authors:  Naoe Okamura; Stephen A Habay; Joanne Zeng; A Richard Chamberlin; Rainer K Reinscheid
Journal:  J Pharmacol Exp Ther       Date:  2008-03-12       Impact factor: 4.030

3.  Structure-activity relationship of imidazopyridinium analogues as antagonists of neuropeptide s receptor.

Authors:  Samarjit Patnaik; Juan J Marugan; Ke Liu; Wei Zheng; Noel Southall; Seameen J Dehdashti; Annika Thorsell; Markus Heilig; Lauren Bell; Michelle Zook; Bob Eskay; Kyle R Brimacombe; Christopher P Austin
Journal:  J Med Chem       Date:  2013-11-11       Impact factor: 7.446

Review 4.  Novel neuropeptides as ligands of orphan G protein-coupled receptors.

Authors:  Yan Zhang; Zhiwei Wang; Gregory Scott Parks; Olivier Civelli
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

5.  Neuropeptide S differently modulates alcohol-related behaviors in alcohol-preferring and non-preferring rats.

Authors:  Nazzareno Cannella; Marsida Kallupi; Hong Wu Li; Serena Stopponi; Carlo Cifani; Roberto Ciccocioppo; Massimo Ubaldi
Journal:  Psychopharmacology (Berl)       Date:  2016-05-28       Impact factor: 4.530

6.  A multiplex calcium assay for identification of GPCR agonists and antagonists.

Authors:  Ke Liu; Noel Southall; Steve A Titus; James Inglese; Robert L Eskay; Paul Shinn; Christopher P Austin; Markus A Heilig; Wei Zheng
Journal:  Assay Drug Dev Technol       Date:  2010-06       Impact factor: 1.738

7.  Neuropeptide s receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders (gastroenterology 2010;138:98-107).

Authors:  Jung Mook Kang
Journal:  J Neurogastroenterol Motil       Date:  2010-04-28       Impact factor: 4.924

Review 8.  The integrative role of the sigh in psychology, physiology, pathology, and neurobiology.

Authors:  Jan-Marino Ramirez
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

9.  Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings.

Authors:  L Raiteri; E Luccini; C Romei; S Salvadori; G Calò
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

10.  Antagonism of the neuropeptide S receptor with RTI-118 decreases cocaine self-administration and cocaine-seeking behavior in rats.

Authors:  Christopher D Schmoutz; Yanan Zhang; Scott P Runyon; Nicholas E Goeders
Journal:  Pharmacol Biochem Behav       Date:  2012-09-12       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.